06224 - 277224

niper.hajipur2007@gmail.com



Publications

2020-21

1. Kumar R, Trivedi V, Chauhan R, Parwez A, Pal B, Murti K, Ravichandiran V, Ali M. Human Papilloma Virus Types 16/18 Distribution in Invasive Cervical Cancer: An Evidence for Vaccination in Bihar, India. Journal of Pharmaceutical Research International. 2020:59-68.
2. Singh S, Shukla R. Key Signaling Pathways Engaged in Cancer Management: Current Update. Current Cancer Therapy Reviews. 2020 Mar 1;16(1):36-48.
3. Giri AE, Rao V, Singhal S, Gourishetti K, Biswas S, Nandakumar K, Chamllamudi MR, Dave J, Dave R, Sumalatha S, Kumar N. Evaluation of hepatoprotective effect of a polyherbal megakutki against paracetamol-induced hepatotoxicity. Indian Journal of Pharmaceutical Education and Research. 2020 Oct 1;54(4):1080-8.
4. Singh S, Singh S. JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis. International Immunopharmacology. 2020 Sep 1;86:106731.
5. Prasanna P, Upadhyay A. Heat shock proteins as the druggable targets in leishmaniasis: promises and perils. Infection and Immunity. 2020 Nov 2;89(2):e00559-20.
6. Singh S, Gautam U, Manvi FV. Protective Impact of Edaravone Against ZnO NPs-induced Oxidative Stress in the Human Neuroblastoma SH-SY5Y Cell Line. Cellular and Molecular Neurobiology. 2020 Nov 21:1-22
7. Rajanala K, Kumar N, Chamallamudi MR. Modulation of Gut-Brain Axis by probiotics: A promising anti-depressant approach. Curr Neuropharmacol. 2020 Dec 15. doi: 10.2174/1570159X19666201215142520.
8. Chunduru K, Sankhe R, Begum F, Sodum N, Kumar N, Kishore A, Shenoy RR, Rao CM, Saravu K. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV. Med Chem. 2021;17(4):380-395. doi: 10.2174/1573396316999200727125522.
9. Kumar N, Shetty M, Shenoy S, Devi V, Amuthan A, Shenoy GK, Pavithra P. Kadukkai maathirai (a polyherbal traditional siddha formulation) prevents D-galactosamine induced hepatic necrosis in rats. Indian Journal of Traditional Knowledge (IJTK). 2020 Dec 28;19(4):708-13.
10. KhanG N, Kumar N, Ballal A, Datta D, Belle, VS, Unveiling Antioxidant and Anticancer Potentials of Characterized Annona Reticulata Leaf Extract in 1,2-Dimethylhydrazine-Induced Colorectal Cancer in Wistar Rats. Journal of Ayurveda and integrative medicine, 2021
11. Dar MA, Chauhan R, Sharma KK, Trivedi Vinita, Dhingra S, Murti K Assessing the reliability and validity of comprehensive score for financial toxicity (COST) among radiation oncology patients in India: a cross-sectional pilot study ecancer. 2021; 15:1219.
12. Moorkoth Prathyusha NS, Manandhar S, Xue Y, Sankhe R, Pai KSR, Kumar N, Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies, Pharmacological Reports, 2021
13. Jindal S, Kumar N, Shah AA, Shah A, Gourishetti K, Chamallamudi MR. Histone Deacetylase Inhibitors Prevented the Development of Morphine Tolerance by Decreasing IL6 Production and Upregulating μ-Opioid Receptors. CNS Neurol Disord Drug Targets. 2021;20(2):190-198. doi: 10.2174/1871527319999201113102852. PMID: 33191889.
14. Sodum N, Kumar G, Rao V, Kumar N, Rao CM. Treatment approaches for COVID-19: A critical review. Mini Rev Med Chem. 2021; 21(13) 1747-1767. doi: 10.2174/1389557521666210224161950.
15. Prasanna P, Upadhyay A. Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go. ACS Pharmacology & Translational Science. 2021 Jan 27;4(1):74-95.
16. Das T, Ranjan A, Sieroń L, Maniukiewicz W, Das S. Direct Synthesis, Characterization and Theoretical Studies of N‐(6‐Amino‐1, 3‐dimethyl‐2, 4‐dioxo‐1, 2, 3, 4‐tetrahydropyrimidin‐5‐yl) benzamide Derivatives. ChemistrySelect. 2021 Jan 27;6(4):726-32.
17. Singh S, Nagalakshmi D, Sharma KK, Ravichandiran V. Natural antioxidants for neuroinflammatory disorders and possible involvement of Nrf2 pathway: A review. Heliyon. 2021 Feb ; 1;7(2):e06216.
18. Pandey RK, Dikhit MR, Lokhande KB, Pandey K, Das P, Bimal S. An immunoprophylactic evaluation of Ld-ODC derived HLA-A0201 restricted peptides against visceral leishmaniasis. J Biomol Struct Dyn. 2021 Feb 19:1-11. doi: 10.1080/07391102.2021.1876773.
19. Sodum N, Kumar G, Bojja SL, Kumar N, Rao CM. Epigenetics in NAFLD/NASH: Targets and therapy. Pharmacological Research. 2021 Mar 24:105484.
20. Pavan G, Choudhary K, Ponnala Vr, Babu R, Veeri Rk, Chattu Vk, Murti K, Dhingra S, Ravichandiran V. COVID-19 impact on the mental health of Indian pharmacy students: An online survey. International Journal of Pharmaceutical Research. 2021 Apr;13(2).
21. Kaur RJ, Dutta S, Bhardwaj P, Charan J, Dhingra S, Mitra P, Singh K, Yadav D, Sharma P, Misra S. Adverse Events reported from Covid-19 vaccine trials: a systematic Review. Indian Journal of Clinical Biochemistry. 2021 Mar 27:1-3.
22. Rao V, Cheruku SP, Manandhar S, Vibhavari RJ, Nandakumar K, Rao CM, Ravichandiran V, Kumar N. Restoring chemo-sensitivity to temozolomide via targeted inhibition of poly (ADP-ribose) polymerase-1 by naringin in glioblastoma. Chemical Papers. 2021 May 28:1-1.
23. Singh S, Dixit A, Ravichandiran V. MCP-1: Function, Regulation, and Involvement in Disease. International Immunopharmacology. 2021 May 20:107598.
24. Dagar N, Das P, Bisht P, Taraphdar AK, Velayutham R, Arumugam S. Diabetic nephropathy: A twisted thread to unravel. Life Sciences. 2021 May 17:119635.
25. Yadav P, Yadav R, Jain S, Vaidya A. Caspase-3: A primary target for natural and synthetic compounds for cancer therapy. Chem Biol Drug Des. 2021 May 8. doi: 10.1111/cbdd.13860. Epub ahead of print. PMID: 33963665.
26. Nayak AG, Kumar N, Shenoy S, Roche M. Evaluation of the merit of the methanolic extract of Andrographis paniculata to supplement anti-snake venom in reversing secondary hemostatic abnormalities induced by Naja naja venom. 3 Biotech. 2021 May;11(5):1-5.
27. Singh S, Agrwal P, Ravichandiran V. Two-pore-domain potassium channel in neurological disorders. Journal of Membrane Biology. 2021 June 17;4(2):1-13.
28. Singh S, Agrwal P, Ravichandiran V. Immunological response of the respiratory tract in the SARS-CoV-2 infection. Coronaviruses. 2021 June 2:2:1-07.
29. Rompicherla SK, Arumugam K, Bojja SL, Kumar N, Rao CM. Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s disease. Naunyn-Schmiedeberg's Archives of Pharmacology. 2021 Jun 4:1-9. https://doi.org/10.1007/s00210-021-02096-0
30. Iskandar K, Molinier L, Hallit S, Sartelli M, Hardcastle TC, Haque M, Lugova H, Dhingra S, Sharma P, Islam S, Mohammed I. Surveillance of antimicrobial resistance in low-and middle-income countries: a scattered picture. Antimicrobial Resistance & Infection Control. 2021 Dec;10(1):1-9.

Book Chapters:

1. Ahmad J, Amin S, Singh S, Mustafa G, Barkat MA. Self-Nanoemulsifying Drug Delivery System for Improving Efficacy of Bioactive Phytochemicals. In Nanophytomedicine 2020 (pp. 71-87). Springer, Singapore.
2. Munindra Ruwali, Keshav Moharir, Sanjiv Singh, Punita Aggarwal and Manash K. Paul (April 26th 2021). Updates in Pharmacogenetics of Non-Small Cell Lung Cancer [Online First], IntechOpen, DOI: 10.5772/intechopen.97498. Available from: https://www.intechopen.com/online-first/updates-in-pharmacogenetics-of-non-small-cell-lung-cancer

2019-20

1. Veeri RB, Gupta AK, Pal B, Siddiqui NA, Priya D, Das P, Pandey K. Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis. Health and quality of life outcomes. (2019), vol-17(1):p 53.
2. Dar MA, Sharma KK. Burden of cancer in india: GLOBOCAN 2018 estimates incidence, mortality, prevalence and future projections in India. International journal of emerging technologies and innovative research. (2019), vol-6(6):p 505-514.
3. Bashir A, Azharuddin M, Rashid I, Murti K, Pandey K. Predictors of cardiomyopathy in patients with type-2 diabetes mellitus with and without cardiovascular complications: A cross-sectional study. Diabetes research and clinical practice. (2019), vol-154:p 90-100.
4. Bashir A, Pandey K, Azharuddin M, Kumari A, Rashid I, Siddiqui NA, Lal CS, Murti K. Association between diet quality scores, adiposity, glycemic status and nutritional biomarkers among Indian population with type 2 diabetes mellitus: A cross-sectional study. Clinical Epidemiology and Global Health. (2019).
5. Khan MI, Mishra A, Jha PK, Abhishek K, Chaba R, Das P, Sinha KK. DNA polymerase β of Leishmania donovani is important for infectivity and it protects the parasite against oxidative damage. Int J Biol Macromol. (2019), vol-124:p 291-303.
6. Bala A, Sunelle R, Kevin NK, Ninesh M, Motlalepula MG. UPLC-MS analysis of Cannabis sativa L using tetrahydrocannabinol (THC), Cannabidiol (CBD) and tetrahydrocannabinolic acid (THCA) as marker compounds: Inhibition of breast cancer cell survival and progression. Natural Product Communications. (2019). p 1-5.
7. Das S. Siddique S, Shehata A.M, Shaker MA, Abdul MIM, Bala A, Mandal P, Dan S, Bose A. Modern approach of treatment on destroyable pathogenicity of malaria parasite: A review article. AJ Pharm and Pharmacol. (2019), vol-13(2):p 6-11.
8. Singh S. Herbal Approach for Management of Atherosclerosis: A Review. Current Atherosclerosis Reports. (2019). (In press).
9. Singh S. Zinc oxide nanoparticles impacts: cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity. Toxicology Mechanisms and Methods. (2019):p 2-12.
10. Kumar P, Shivam P, Mandal S, Prasanna P, Kumar S, Prasad SR, Kumar A, Das P, Ali V, Singh SK, Mandal D. Synthesis, characterization and mechanistic studies of a gold nanoparticle– Amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity. International Journal of Nanomedicine. (2019), vol-14:p 6073-6101.
11. Bala A, Panditharadyula SS. Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF-2) Mediated Antioxidant Response on the Synergistic Antitumor Effect of L-Arginine and 5-Fluro Uracil (5FU) in Breast Adenocarcinoma. Curr Pharm Des. (2019), vol-25(14):p 1643-1652.
12. Kumari S, Prasad SR, Mandal D. Das P. Carbon Dot-DNA- Protoporphyrin Hybrid Hydrogel for Sustained Photoinduced Antimicrobial Activity. J Colloid Interface Sci. (2019), vol-553:p 228-238.
13. Mandal S, Prasad SR, Mandal D, Das P. BSA amplified ROS generation from Anthrarufin derived Carbon dot and concomitant Nanoassembly for combination antibiotic- photodynamic therapy application. ACS Applied materials and Interfaces. (2019), vol-11(36):p 33273-33284.
14. Bala A, Mondal C, Haldar PK. Zebra Fish in Toxicology Research: Streptavidin conjugated peroxidase assay in development phase of zebra fish embryos to study liver toxicities. Curr Drug Discov Technol. (2019).
15. Singh S, Singh AG. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis. Current Atherosclerosis Reports. (2019), vol-21:p 38.
16. Singh S, Pawar A. Effect of radio frequency electromagnetic field from mobile phones’ base station antennas on maturation of rat erythrocytes. Comparative Clinical Pathology. (2019), vol-22:p 14.
17. Kant V, Vijayakumar S, Sahoo GC, Ali V, Singh K, Chaudhery SS, Das P. In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS).J Biomol Struct Dyn. (2019), vol-37(2):p 481-492.
18. Vijayakumar S, Kant V, Das P. LeishInDB: A web-accessible resource for small molecule inhibitors against Leishmania sp.Acta Trop. (2019), vol-190:p 375-379.
19. Mandal H, Vijayakumar S, Yadav S, Kumar Singh S, Das P.Validation of NAD synthase inhibitors for inhibiting the cell viability of Leishmania donovani: In silico and in vitro approach.J Biomol Struct Dyn. (2019), vol-37(17):p 4481-4493.

2018

1.Garapati P, Pal B, Siddiqui NA, Bimal S, Das P, Murti K, Pandey K. Knowledge, stigma, health seeking behaviour and its determinants among patients with post kala azar dermal leishmaniasis, Bihar, India. PloS one. (2018), Vol-13(9).e 0203407
2. Kumari B, Sinha KK, Das P. Complex interplay of lesion-specific DNA repair enzyme on bistranded clustered DNA damage harboring Tg : G mismatch in nucleosome core particles. J Biosci. (2018), Vol-43(4):p 575-583.
3.SinghS, Shukla R. Key Signaling Pathways Engaged in Cancer Management. Current Update Current Cancer Therapy Reviews. (2018).
4. Garg G, Singh K, Ali V. Proteomic approaches unravel the intricacy of secreted proteins of Leishmania: An updated review. Biochim Biophys Acta Proteins Proteom. (2018), vol-1866(8):p 913-923.
5. Mishra A, Khan MI, Jha PK, Kumar A, Das S, Das P, Das P, Sinha KK. Oxidative Stress-Mediated Overexpression of Uracil DNA Glycosylase in Leishmania donovani Confers Tolerance against Antileishmanial Drugs. Oxid Med Cell Longev. (2018), vol- 25:e 4074357.

2017

1. Singh J, Khan MI, Yadav SPS, Srivastava A, Sinha KK, Ashish, Das P, Kundu B. L-Asparaginase of Leishmania donovani: Metabolic target and its role in Amphotericin B resistance. International Journal for Parasitology: Drugs and Drug Resistance. (2017), vol-7(3):p 337-349.
2. Kumari R, Khan MI, Bhowmick S, Sinha KK, Das N, Das P. Self-assembly of DNA-porphyrin hybrid molecules for the creation of antimicrobial nanonetwork. Journal of Photochemistry and Photobiology B: Biology. (2017), vol-172:p 28–35.
3. Jha PK, Khan MI, Mishra A, Das P, Sinha KK. HAT2 Mediates Histone H4K4 acetylation and affects micrococcal nuclease sensitivity of chromatin in Leishmania donovani. Plos One. (2017), vol-12(5):e 0177372.
4. Sinha KK, Peddada N, Jha PK, Mishra A, Pandey K, Das VNR, Ashish, Das P. Plasma Gelsolin Level in HIV-1-Infected Patients: An Indicator of Disease Severity. AIDS Res Hum Retroviruses. (2017), vol-33(3):p 254-260.
5. Singh S, Mishra A, Kumari R, Sinha KK, Singh MK, Prolay Das. Carbon dots assisted formation of DNA hydrogel for sustained release of drug. Carbon. (2017), vol-114:p 169-176.
6. Pal B, Murti K, Siddiqui NA, Das P, Lal CS, Babu R, Rastogi MK, Pandey K. Assessment of quality of life in patients with post kalaazar dermal leishmaniasis. Health and quality of life outcomes. (2017), vol-15(1):p 148.
7. Kumar R, Rabidas V, Pal B, Topno RK, Agarwal K, Babu R, Lal CS, Verma N, Das P, Pandey K. A relapse case of HIV-PKDL co-infection associated with diabetes and its microvascular complications. Asian Pac J Trop Dis. (2017), vol-7(3):p 183-184.
8. Pandey K, Pal B, Siddiqui NA, Das VN, Murti K, Lal CS, Verma N, Babu R, Ali V, Kumar R, Das P. Efficacy and safety of liposomal amphotericin B for visceral leishmaniasis in children and adolescents at a tertiary care center in Bihar, India. The American journal of tropical medicine and hygiene. (2017), vol-97(5):p 1498-502.
9. Pandey K, Pal B, Das VN, Murti K, Lal CS, Verma N, Bimal S, Ali V, Verma RB, Topno RK, Siddiqi NA. Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot study. The British journal of dermatology. (2017), vol-177(2):p 557.
10. Singh M, Gupta AK, Singh JK, Rastogi MK, Das P, Pandey K, Nath A. Effect of age and sex under imatinibmesylate therapy on chronic myeloid leukaemia patients: a pilot study from india. International Journal of Pharmaceutical Sciences and Research. (2017), vol-8(4):p 1727.
11. Murti K, Chandran V, Kumar A, Ghalot V, Rastogi MK, Pal B, Pandey K, Das P. Comparative survival and safety analysis of cisplatin based regimens in gall bladder cancer patients: A retrospective cohort study. Biomed Res- India. (2017), Vol-28(9) :p 4171-4176.
12. Murti K, Krishna RK, Rastogi MK, Ali M, Gahlot VV, Lal CS, Das P. Pharmacovigilance Study on Platinum-based Chemotherapeutic Regimens in Oral Cancer Patients: A Prospective Cohort Study. Indian Journal of Pharmaceutical Sciences. (2017), vol-78(6):p 741-7.
13. Mansuri R, Kumar A, Rana S, Panthi B, Ansari MY, Das S, Dikhit MR, Sahoo GC, Das P. In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance. Antimicrob Agents Chemother. (2017), vol-61(7).e 02429-16.
14. Bala A, Mondal C., Haldar PK, Khandelwal B. Oxidative stress in inflammatory cells of patient with Rheumatoid Arthritis: Clinical Efficacy of Dietary Antioxidants. Inflammopharmacol. (2017), vol-25(6):p 595-607.
15. Singh M, Gupta AK, Singh JK, Rastogi MK, Das P, Pandey K, Nath A. A study on effect of Age and Sex under Imatinib mesylate therapy for Chronic Myeloid Leukemia patients. International Journal of Pharmaceutical Sciences and Research. (2017), vol-8(4):p 1727-1733.
16. Singh K, Ali V, Pratap SK, Gupta P, Suman SS, Ghosh AK, Bimal S, Pandey K, Das P. Deciphering the interplay between cysteine synthase and thiol cascade proteins in modulating Amphotericin B resistance and survival of Leishmania donovani under oxidative stress. Redox Biol. (2017), vol-12:p 350-366.
17. Singh MK, Bhaumik SK, Karmakar S, Paul J, Sawoo S, Majumder HK, Roy A. Copper salisylaldoxime (CuSAL) imparts protective efficacy against visceral leishmaniasis by targeting Leishmania donovani topoisomerase IB.Exp Parasitol. (2017), vol-175:p 8-20.

2016

1. Pal B, Murti K, Gupta AK, Choudhury U, Rastogi M, Pandey H. Self medication with antibiotics among medical and pharmacy students in North India. Curr Res Med. (2016), vol-7(2):p 7.
2. Garg R, Kumar R, Nathiya D, Goshain O, Trivedi V, Sharma AK, Murti K. Comparative acute toxicity studies of selected indigenous herbal plants in Swiss albino mice. IOSR J Pharm Biol Sci. (2016), vol-11:p 20-7.
3. Murti K, Sethi MK, Dey A, Lal CS, Pandey K, Das P. Addition of Voglibose to Glimepiride and Metformin have Better Glucose Control in Diabetics: A Prospective, Parallel-group and Open-label Comparative Study. Pharmacology. (2016), vol-12(4):p 422-8.
4. Kumar R, Das VN, Topno RK, Pal B, Imam A, Agrawal K, Singh A, Murti K, Lal CS, Verma N, Das P. Para-kala-azar dermal Leishmaniasis cases in Indian subcontinent–A case series. Pathogens and global health. (2016), vol-110(7-8):p 326-9.
5. Saini S, Ghosh AK, Singh R, Das S, Kumar A, Verma S, Mandal A, Sardar AH, Purkait B, Kumar A, Sinha KK, Das P. Glucose deprivation induced upregulation of phosphoenolpyruvate carboxykinase modulates virulence in Leishmania donovani. Molecular Microbiology. (2016), vol-102(6):p 1020-1042.
6. Singh S, Jha P, Singh V, Sinha K, Hussain S, Singh MK, Das P. A quantum dot–MUC1 aptamer conjugate for targeted delivery of protoporphyrin IX and specific photokilling of cancer cells through ROS generation. Integrative Biology. (2016), vol-8:p 1040-1048.
7. Vijayamahantesh, Amit A, Kumar S, Dikhit MR, Jha PK, Singh AK, Sinha KK, Pandey K, Das VNR, Das P, Bimal S. Up regulation of A2B adenosine receptor on monocytes are crucially required for immune pathogenicity in Indian patients exposed to Leishmania donovani. Cytokine. (2016), vol-79:p 38-44.
8. Kumar R, Das VN, Topno RK, Pal B, Imam A, Agrawal K, Singh A, Murti K, Lal CS, Verma N, Das P, Pandey K. Post-kala-azar dermal Leishmaniasis cases in Indian subcontinent-A case series.Pathog Glob Health. (2016), vol-110(7-8):p 326–329.
9. Pal B, Murti K, Gupta AK, Choudhury U, Rastogi MK, Pandey H, Lal CS, Pandey K and Das P. Self-medication with Antibiotics among Medical and Pharmacy Students in North India. Current Research in Medicine. (2016), Vol-7(2):p 7-12.
10. Ansari MY, Equbal A, Dikhit MR, Mansuri R, Rana S, Ali V, Sahoo GC, Das P. Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors. Int J Biol Macromol. (2016), vol-83:p 78-96.
11. Mansuri R, Ansari MY, Singh J, Rana S, Sinha S, Sahoo GC, Dikhit MR, Das P. Computational Elucidation of Structural Basis for Ligand Binding with Mycobacterium tuberculosis Glucose-1-Phosphate Thymidylyltransferase (RmlA). Curr Pharm Biotechnol. (2016), vol-17(12):p 1089-1099.
12. Jensen NF, Agama K, Roy A, Smith DH, Pfister TD, Rømer MU, Zhang HL, Doroshow JH, Knudsen BR, Stenvang J, Brünner N, Pommier Y.Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.J Exp Clin Cancer Res. (2016), vol-35:p 56.
13. Pathan AA, Panthi B, Khan Z, Koppula PR, Alanazi MS, Sachchidanand, Parine NR, Chourasia M. Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches.Onco Targets Ther. (2016), vol-9:p 2575-84.
14. Singh AK, Umar S, Riegsecker S, Chourasia M, Ahmed S. Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6.Arthritis Rheumatol. (2016), vol-68(2):p 347-58.
15. Kozela E, Haj C, Hanuš L, Chourasia M, Shurki A, Juknat A, Kaushansky N, Mechoulam R, Vogel Z. HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells.Chem Biol Drug Des. (2016), 87(1):p 143-53.

2015

1. Murti K, Khan MA, Dey A, Sethi MK, Das P, Pandey K. Prescription pattern of anti-hypertensive drugs in adherence to JNC-7 guidelines. American Journal of Pharmacology and Toxicology. (2015), vol-10(1):p 27.
2. Kumar R, Trivedi V, Murti K, Dey A, Singh JK, Nath A, Das P. Arsenic exposure and haematological derangement in cervical cancer cases in India. Asian Pac. J. Cancer Prev. (2015), vol-16:p 6397-400.
3. Nath A, Kumar S, Singh M, Nadeem T, Murti K, Gupta AK, Das P, Priyanka, Kumar A. Combined assessment of lipid peroxidation, cea and ca19.9 bio-markers in advanced stage gall bladder cancer. International Journal of Recent Scientific Research. (2015), vol-6(3):p 3136-3141.
4. Nath A, Kumar R, Trivedi V, Murti K, Kumar S, Singh CK, Singh JK, Das P. MDA elevation and haematological derangements at first clinical presentation in cervical cancer patients. Int J Pharm Sci Rev Res. (2015):p 175-9.
5. Singh J, Srivastava A, Jha P, Sinha KK, Kundu B. L-Asparaginase as a new molecular target against leishmaniasis: insights into the mechanism of action and structure based inhibitor design. Molecular Biosystems. (2015), vol-11(7):p 1887-96.
6. Bhattacharya A, Köhrer C, Mandal D, RajBhandary UL. Nonsense suppression in Archaea. PNAS. (2015), vol-112(19):p 6015-6020.

2014

1. Bhatnagar S, Gupta AK, Murti K, Pandey K. Co–infection of visceral leishmaniasis and pulmonary tuberculosis: a case study. Asian Pacific Journal of Tropical Disease. (2014), vol-4(1):p 57-60.
2. Khan AM, Pandey RK, Nadeem T, Sethi MK, Sharma S, Murti K, Gupta A, Pandey K. Complicated case of rheumatic heart disease; unexplored for years. OnLine Journal of Biological Sciences. (2014), vol-14(1):p 44.
3. Pandey K, Singh D, Bimal S, Murti K, Das P. Association of testosterone and cholesterol level in modulation of immunity and severity of disease in visceral leishmaniasis patients-a preliminary study. American Journal of Immunology. (2014), vol-10(1):p 46.
4. Das VR, Singh D, Murti K, Das S, Das P, Pandey K. Post kala-azar dermal leishmaniasis with ulceration on foot: an atypical case presentation successfully treated with miltefosine. American Journal of Infectious Diseases. (2014), vol-10(2):p 50.
5. Negi H, Sarkar M, Raval AD, Pandey K, Das P. Presence of depression & its risk factors in patients with chronic obstructive pulmonary disease. The Indian journal of medical research. (2014), vol-139(3):p 402.
6. Sunny A, kumar GR, Sudhakar SK, Murti K, Gupta AK. Recurrent visceral leishmaniasis in a HIV positive patient-a case report. Journal of Coastal Life Medicine. (2014), vol-2(1):p 46-48.
7. Sethi Mk, singh D, murti K, chaudary SS, Pandey K, Das P.DPP-4 Inhibitors a novel approach for management of type 2 diabetes mellitus. World Journal of Pharmaceutical Sciences. (2014), Vol-2(10):p 1395-1400.
8. Pandey K, Singh D, Bimal S, Das VNR, Murti K, Lal CS and Das P. Newer Drugs for Visceral Leishmaniasis: A Review. American Journal of Infectious Diseases. (2014), vol-10(2):p 68-70.
9. Sethi MK, Khan MA, Murti K, Singh D, Das P, Pandey K. Co-Infection of Neurocysticercosis and Intracranial Tuberculoma: A Rare Case. International Journal of Pharmaceutical Science and Health Care. (2014), Vol-3(4).
10. Khan MA, Murti K, Grover V, Lal K, Singh D, Das P. Atorvastatin Vs Rousuvastatin: Fenofibrate as AN Add On: An Exploratory Study. International Journal of Pharmacy & Pharmaceutical Sciences. (2014), vol-6(8):p 1-6.

2013

1. Bhatnagar S, Shweta, Murti K, Gupta A, Sudhakar S. Adverse effects of amphotericin b in patients of visceral leishmaniasis: a short survey at research hospital patna. American Journal of Virology. (2013), vol-2:p 20-24.
2. Khan MA, Kumar RV, Pandey K, Murti K, Gupta AK. Epidemiological survey of visceral Leishmaniasis: An evidence based report. American Journal of Infectious Diseases. (2013), vol-9(2):p 59-62.
3. Sardar AH, Kumar S, Kumar A, Purkait B, Das S, Sen A, Kumar M, Sinha KK, Singh D, Equbal A, Ali V, Das P. Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses. Journal of Proteomics. (2013), vol-81:p 185-99.